EVERTEC, Inc. Stock Compensation Disclosure
| Nonvested RSUs | Shares | Weighted average grant date fair value | ||||||||||||
| Nonvested at December 31, 2022 | 1,363,780 | $ | 38.96 | |||||||||||
| Granted | 1,072,494 | 37.53 | ||||||||||||
| Vested | (608,800) | 36.92 | ||||||||||||
| Forfeited | (28,462) | 39.46 | ||||||||||||
| Nonvested at December 31, 2023 | 1,799,012 | 39.42 | ||||||||||||
| Granted | 1,161,455 | 36.76 | ||||||||||||
| Vested | (791,833) | 39.25 | ||||||||||||
| Forfeited | (164,370) | 36.01 | ||||||||||||
| Nonvested at December 31, 2024 | 2,004,264 | 38.71 | ||||||||||||
| Granted | 856,615 | 39.13 | ||||||||||||
| Vested | (710,439) | 39.69 | ||||||||||||
| Forfeited | (115,814) | 38.62 | ||||||||||||
| Nonvested at December 31, 2025 | 2,034,626 | $ | 38.59 | |||||||||||
| Years ended December 31, | |||||||||||||||||
| (In thousands) | 2025 | 2024 | 2023 | ||||||||||||||
| Share-based compensation recognized, net | |||||||||||||||||
| RSUs | $ | 29,582 | $ | 30,275 | $ | 25,732 | |||||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 2, 2026 | Showing above |
| 2024 | Mar 3, 2025 | |
| 2023 | Feb 29, 2024 | |
| 2022 | Feb 24, 2023 | |
| 2021 | Feb 25, 2022 | |
| 2020 | Mar 1, 2021 | |
| 2019 | Feb 27, 2020 | |
| 2018 | Feb 26, 2019 | |
| 2017 | Feb 28, 2018 | |
| 2016 | Feb 24, 2017 | |
| 2015 | May 26, 2016 | |
About Stock Compensation Disclosures
Stock-based compensation disclosures detail the equity awards granted to employees and executives — including stock options, restricted stock units (RSUs), and performance shares — along with the valuation methods and assumptions used to expense them. This section reveals the true cost of talent retention and the alignment between management incentives and shareholder interests.
Key signals: total unrecognized compensation expense and its expected recognition period signal future earnings headwinds from already-granted awards. For stock options, examine Black-Scholes assumptions — expected volatility, risk-free rate, and expected term — as understating any of these reduces reported compensation expense. Compare stock compensation expense as a percentage of revenue against peers to assess dilution cost. Watch vesting schedules for acceleration clauses tied to change-of-control events. Performance-based awards with undemanding targets may indicate weak governance. Add back stock compensation to operating cash flow to calculate a more conservative free cash flow figure.